Skip to search formSkip to main contentSkip to account menu

Lys-Nva-FMDP

Known as: L-Lysyl-L-Norvalyl-N(3)-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid 
National Institutes of Health

Related topics

Related topics

2 relations
analogs & derivatives

Broader (1)

beta-Alanine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Antifungal activity of thionated analogues of Nva-FMDP and Lys-Nva-FMDP.
The antifungal activity of synthetic endothiopeptdides, i.e. Nva(psi)[CSNH]-FMDP and Lys(psi)[CSNH]-Nva(psi)[CSNH]-FMDP was… 
1998
1998
[Synthesis and anti-Candida albicans properties of L-4-oxalysine-N3-4-methoxyfumaroyl-L-2,3-diaminopropanoic-containing peptide analogues].
In order to improve the inhibitory activity of L-4-oxalysine(abbreviated as I-677) against clinically important pathogen Candida… 
1997
1997
[Determination of degradation level of antifungal agent in mice serum by high performance liquid chromatography].
L-4-oxalysinyl-norvalinyl-N3-4-methoxyfumaroyl-L-2,3-diaminopropanoic acid (I-677-Nva-FMDP) is a new tripeptide synthesized in… 
Highly Cited
1988
Highly Cited
1988
Glucosamine synthetase from Escherichia coli: kinetic mechanism and inhibition by N3-fumaroyl-L-2,3-diaminopropionic derivatives.
N3-(4-Methoxyfumaroyl)-L-2,3-diaminopropionic acid (FMDP; 1, R = OMe), a member of a new class of glutamine analogues, has been… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)